Get the Stockscreener App
0.2907
1.89%
-0.0056
After Hours:
.30
0.0093
+3.20%
Leap Therapeutics Inc stock is traded at $0.2907, with a volume of 339.04K.
It is down -1.89% in the last 24 hours and down -19.18% over the past month.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
See More
Previous Close:
$0.2963
Open:
$0.2855
24h Volume:
339.04K
Relative Volume:
0.19
Market Cap:
$12.05M
Revenue:
$1.50M
Net Income/Loss:
$-64.59M
P/E Ratio:
-0.1741
EPS:
-1.67
Net Cash Flow:
$-55.17M
1W Performance:
+8.31%
1M Performance:
-19.18%
6M Performance:
-37.28%
1Y Performance:
-90.18%
1-Day Range:
$0.2855
$0.2999
1-Week Range:
$0.2625
$0.32
52-Week Range:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Name
Leap Therapeutics Inc
Sector
Industry
Phone
617 252 4343
Address
47 THORNDIKE STREET, CAMBRIDGE, MA
Compare LPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.2907 | 12.28M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-29-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-28-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-04-21 | Initiated | Mizuho | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Jun-29-20 | Initiated | Piper Sandler | Overweight |
| Feb-11-20 | Initiated | Robert W. Baird | Outperform |
| Nov-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-13-19 | Resumed | Raymond James | Outperform |
| Mar-07-17 | Initiated | Ladenburg Thalmann | Buy |
View All
Leap Therapeutics Inc Stock (LPTX) Latest News
Custom watchlist performance reports with Leap Therapeutics Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - Newser
Will Leap Therapeutics Inc. see short term momentumTrade Risk Report & Fast Exit/Entry Strategy Plans - Newser
How to recover losses in Leap Therapeutics Inc. stockJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
How to escape a deep drawdown in Leap Therapeutics Inc.Oil Prices & Daily Momentum Trading Reports - Newser
How hedge fund analytics apply to Leap Therapeutics Inc. stockWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
Using R and stats models for Leap Therapeutics Inc. forecastingJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser
Is Leap Therapeutics Inc. stock entering bullish territoryWeekly Loss Report & Community Driven Trade Alerts - Newser
Applying Elliott Wave Theory to Leap Therapeutics Inc.July 2025 Setups & Weekly Watchlist for Hot Stocks - Newser
Strategies to average down on Leap Therapeutics Inc.Global Markets & Stock Timing and Entry Methods - Newser
News impact scoring models applied to Leap Therapeutics Inc.Trade Volume Summary & Fast Entry and Exit Trade Plans - Newser
Relative strength of Leap Therapeutics Inc. in sector analysisJuly 2025 Fed Impact & Free Long-Term Investment Growth Plans - Newser
Chartists Watching For Breakout in Leap Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Does Leap Therapeutics Inc. fit your quant trading model2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
What data driven models say about Leap Therapeutics Inc.’s futureM&A Rumor & Safe Swing Trade Setups - Newser
What indicators show strength in Leap Therapeutics Inc.July 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
Bullish Candlestick Pattern Forms in Leap Therapeutics Inc.Bear Alert & Weekly Return Optimization Alerts - 더경남뉴스
Moving Average Crossover Confirms Uptrend in Leap Therapeutics Inc.July 2025 Levels & Safe Entry Point Alerts - kangso.co.kr
Is it time to cut losses on Leap Therapeutics Inc.2025 Dividend Review & Short-Term High Return Ideas - Newser
Is Leap Therapeutics Inc. exposed to political risk2025 Growth vs Value & High Win Rate Trade Tips - theviewers.co.kr
What’s next for Leap Therapeutics Inc. stock price2025 Price Momentum & Weekly Setup with ROI Potential - Newser
What technical models suggest about Leap Therapeutics Inc.’s comebackBuy Signal & Reliable Price Breakout Signals - Newser
Has Leap Therapeutics Inc. found a price floorMarket Volume Report & Weekly High Momentum Picks - Newser
Leap Therapeutics Inc. Charts Flash Early Recovery SignalsJuly 2025 News Drivers & Target Return Focused Stock Picks - 더경남뉴스
Pattern recognition hints at Leap Therapeutics Inc. upsideEarnings Trend Report & Daily Oversold Stock Bounce Ideas - Newser
What earnings revisions data tells us about Leap Therapeutics Inc.Breakout Watch & Risk Controlled Stock Pick Alerts - Newser
Leap Therapeutics shares rise 3.27% premarket after Natera's AI foundation model launch. - AInvest
How to monitor Leap Therapeutics Inc. with trend dashboardsQuarterly Earnings Summary & Daily Technical Forecast Reports - Newser
What recovery options are there for Leap Therapeutics Inc.July 2025 Price Swings & High Conviction Trade Alerts - Newser
Does Leap Therapeutics Inc. show high probability of reboundJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Chart overlay techniques for tracking Leap Therapeutics Inc.2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
Leap Therapeutics Inc Stock (LPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):